Michael Fitzpatrick joins Personalis as Vice President Worldwide Sales

Menlo Park, CA – April 30, 2013 – Personalis today announced the appointment of Michael Fitzpatrick as Vice President Worldwide Sales. Mr. Fitzpatrick brings substantial experience in sales and sales operations in the life science industry, specifically related to DNA sequencing. In this newly created position, Mr. Fitzpatrick will be instrumental in helping drive the next phase of the company’s growth strategy.

Michael Fitzpatrick has 30 years of experience in global sales, new product and technology introductions and market development. Prior to joining Personalis, Mr. Fitzpatrick spent 20 years at Applied Biosciences, Inc. where he started as a Senior Sales Consultant. He also held various positions of increasing authority including Vice President of North American Sales and Field Operations, Vice President of Sales of the Molecular Biology Division and Vice President of Global Key Accounts. This tenure spanned the entire Human Genome Project and the subsequent transition to re-sequencing for disease research. Mr. Fitzpatrick later served as Vice President of Global Sales and Commercial Development at OpGen, Inc. In this role, he was responsible for establishing global sales and support channels in North America, Europe and Asia. Prior to joining OpGen, he was the Vice President of Global Sales and Support at Codon Devices, Inc. where he was the first commercial team member who built out their global sales and support teams.

“Mike brings a wealth of highly relevant experience in sales and sales operations to this important leadership role at Personalis,” said John West, CEO of Personalis. “As we look to accelerate the growth in next generation sequencing interpretation and analysis and focus on large market opportunities, he will play a key role in helping us achieve this goal.” Mr. Fitzpatrick added “I am thrilled to be joining the Personalis team and rapidly building the global commercial organization. The market opportunity is enormous and Personalis is in the perfect position to address the NGS analysis bottleneck.”

In this new position, Mr. Fitzpatrick will oversee the day-to-day management of Personalis’ worldwide sales, including field sales and support

About Personalis, Inc.

Personalis, Inc. (www.personalis.com) is a leading precision medicine company focused on advanced NGS-based clinical diagnostic, clinical trial and research services for cancer and inherited genetic disease.  Personalis also provides DNA sequencing and data analysis of human genomes.

The Personalis ACE Exome and Transcriptome technology is designed to obtain the most comprehensive and accurate tumor molecular profile for immuno-oncology applications. The company’s clinical laboratory is GCP compliant, CLIA licensed and CAP accredited.

Media Contact for Personalis:

Jennifer Havlek